The Valley Desk

NCT01163032 · Interventional trial

Efficacy and Safety of Tasimelteon Compared With Placebo in Totally Blind Subjects With Non-24-Hour Sleep-Wake Disorder

Overall registry status Completed

Phase 3

Conditions Non-24-Hour Sleep-Wake Disorder

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov